Bulk Inquiry
R 406
Axon 1674
CAS:
841290-80-0
Purity:
98%
- Soluble in DMSO
- MF: C22H23FN6O5
- MW: 470.45
Description
Orally bioavailable and selective inhibitor of spleen tyrosine kinase (Syk) (Ki=30 nM). Active component of its prodrug R788 or R935788 (Fostamatinib)
More Information
| Parent CAS No. | 841290-80-0 |
|---|---|
| Chemical Name | 6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one |
| SMILES | N1C(=O)C(C)(C)OC2C=CC(=NC1=2)NC1=C(F)C=NC(NC2C=C(OC)C(=C(OC)C=2)OC)=N1 |
| MFCD | MFCD09970820 |
| InChi | InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30) |
| InChiKey | NHHQJBCNYHBUSI-UHFFFAOYSA-N |
| CID | 11213558 |
| Short Description | Syk inhibitor |
References
- S Braselmann et al. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J. Pharmacol. Exp. Ther. 2006, 319(3), 998-1008.
- HS Cha et al. A Novel Spleen Tyrosine Kinase Inhibitor Blocks c-Jun N-Terminal Kinase-Mediated Gene Expression in Synoviocytes. J. Pharmacol. Exp. Ther. 2006, 317(2), 571-578.
- JC Spalton et al. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J. Thromb. Haemost. 2009, 7, 1-8.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1936 | P 505-15 |
From $99.00 |
| 2775 | Cerdulatinib |
From $93.50 |
| 3997 | ASN-002 |
From Inquiry |
| 4153 | GS-9973 |
From Inquiry |
| 4242 | UNC-CA2-103 |
From $143.00 |
Other Categories
Get a Quote for
Loading...
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.